Last reviewed · How we verify

Thiazide Treatment Group — Competitive Intelligence Brief

Thiazide Treatment Group (Thiazide Treatment Group) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Thiazide diuretic. Area: Cardiovascular.

marketed Thiazide diuretic Sodium-chloride cotransporter (NCC) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Thiazide Treatment Group (Thiazide Treatment Group) — Cedars-Sinai Medical Center. Thiazide diuretics reduce blood pressure by decreasing sodium reabsorption in the distal convoluted tubule of the kidney, leading to increased sodium and water excretion and reduced blood volume.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Thiazide Treatment Group TARGET Thiazide Treatment Group Cedars-Sinai Medical Center marketed Thiazide diuretic Sodium-chloride cotransporter (NCC)
olmesartan medoxomil-hydrochlorothiazide OLMESARTAN Cosette marketed Thiazide Diuretic [EPC] 2019-01-01
Benicar OLMESARTAN MEDOXOMIL Cosette marketed Thiazide Diuretic [EPC] Type-1 angiotensin II receptor 2002-01-01
Zestril lisinopril Generic (originally Merck/AstraZeneca) marketed Thiazide Diuretic [EPC] Angiotensin-converting enzyme, Angiotensin-converting enzyme 1987-12-29
Capozide 25/15 CAPTOPRIL Aarxion Anda Hlding marketed Thiazide Diuretic [EPC] Renin 1981-01-01
TRIAMTERENE TRIAMTERENE marketed Thiazide Diuretic [EPC] 1964-01-01
Enduron methylclothiazide marketed Thiazide Diuretic Solute carrier family 12 member 3 1960-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Thiazide diuretic class)

  1. Cedars-Sinai Medical Center · 2 drugs in this class
  2. National University of Ireland, Galway, Ireland · 1 drug in this class
  3. Bristol-Myers Squibb · 1 drug in this class
  4. Seiji Umemoto, M.D., Ph.D. · 1 drug in this class
  5. Takeda · 1 drug in this class
  6. University of Virginia · 1 drug in this class
  7. Novartis · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Thiazide Treatment Group — Competitive Intelligence Brief. https://druglandscape.com/ci/thiazide-treatment-group. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: